Feng Lin

机构：City College of San Francisco, University of California, San Francisco, Peking University, Beijing Chao-Yang Hospital, Capital Medical University, Qujing Normal University, Sanofi (United States), Peking University First Hospital, Shanghai University of Medicine and Health Sciences · ORCID：0000-0002-6134-4937

发表论文 219 篇 · 总被引 10437 次 · h-index 55

代表论文

• Association of nirmatrelvir for acute SARS‐CoV‐2 infection with subsequent Long COVID symptoms in an observational cohort study (2024 · Journal of Medical Virology · 被引 54)
• Multi-kingdom gut microbiota dysbiosis is associated with the development of pulmonary arterial hypertension (2025 · EBioMedicine · 被引 13)
• Effects of Chinese heart-healthy diet on blood lipids, glucose, and estimated 10-y cardiovascular disease risk among Chinese adults: results on secondary outcomes of a randomized controlled trial (2023 · American Journal of Clinical Nutrition · 被引 12)
• Impact of Heating Conventional Cigarettes With a Novel Device on Health-Related Biomarkers and Cigarette Use Patterns Among Chinese Adult Smokers Unwilling to Quit: A Pilot Randomized Controlled Trial (2024 · Nicotine & Tobacco Research · 被引 9)
• Increased in-hospital mortality and readmission risk associated with cardiovascular and cerebrovascular comorbidities in acute exacerbation of COPD patients (2025 · BMJ Open Respiratory Research · 被引 8)
• Tracking COPD exacerbation patterns and forecasting readmission risks utilizing electronic medical records (2024 · International Journal of Medical Informatics · 被引 5)